Author

Paul Scholl

EFFICACY AND SAFETY OF RE-INDUCTION TREATMENT WITH THE SELECTIVE IL-23 INHIBITOR RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN?S DISEASE

Brian G. Feagan, William Sandborn, Julian Panés, Marc Ferrante, Edouard Louis, Geert R. D'Haens, Denis Franchimont, Arthur Kaser, Olivier Dewit, Ursula Seidler, Kyung-Jo Kim, Markus F. Neurath, Paul Scholl, Sudha Visvanathan, Steven J Padula, Ivona Herichova, Nanshi Sha, David Hall, Wulf O. Böcher

Item 1 - 1 / 1
1